Kingdon Capital Management, L.L.C. Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $16.6 Million - $29.2 Million	-200,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $4.99 Million - $7.42 Million	50,000 Added 33.33%	200,000 $27.6 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $3.25 Million - $4.91 Million	50,000 Added 50.0%	150,000 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $2.89 Million - $7.4 Million	99,700 Added 33233.33%	100,000 $7.31 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $4.07 Million - $5.75 Million	-99,700 Reduced 99.7%	300 $16,000
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $3.45 Million - $5.33 Million	100,000 New	100,000 $5.15 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.